Transcriptomics and lipidomics, alongside ROS, ferroptosis, and p53 inhibitors, were applied to uncover mechanisms.<h4>Results</h4>ACSL1 is markedly downregulated in ccRCC and predicts poor prognosis. Here, ACSL1 is linked to nonpapillary renal cell carcinoma.